Consolidated Statement Of Cash Flows

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572450

Concept 2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
214,733,000,000 JPY
214,733,000,000 JPY
JPY
JPY
JPY
214,733,000,000 JPY
JPY
JPY
157,560,000,000 JPY
157,560,000,000 JPY
JPY
157,560,000,000 JPY
JPY
Other
694,000,000 JPY
-2,741,000,000 JPY
Subtotal
271,820,000,000 JPY
241,423,000,000 JPY
Income taxes paid
-66,785,000,000 JPY
-34,782,000,000 JPY
Net cash provided by (used in) operating activities
205,035,000,000 JPY
206,641,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-57,040,000,000 JPY
-53,009,000,000 JPY
Proceeds from sale of property, plant and equipment
-22,000,000 JPY
119,000,000 JPY
Purchase of intangible assets
-4,349,000,000 JPY
-8,168,000,000 JPY
Purchase of investment securities
-177,000,000 JPY
-1,013,000,000 JPY
Proceeds from sale of investment securities
319,000,000 JPY
6,743,000,000 JPY
Other
JPY
0 JPY
Net cash provided by (used in) investing activities
-98,312,000,000 JPY
-81,741,000,000 JPY
Cash flows from financing activities
Proceeds from exercise of employee share options
440,000,000 JPY
735,000,000 JPY
Other
JPY
-16,000,000 JPY
Net cash provided by (used in) financing activities
-99,497,000,000 JPY
-66,872,000,000 JPY
Cash and cash equivalents
212,333,000,000 JPY
203,941,000,000 JPY
146,860,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
1,166,000,000 JPY
-947,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.